NCT06737458View on ClinicalTrials.gov

Serratus Anterior Plane Block Versus Erector Spinae Plane Block With Dexmedetomidine Added to Bupivacaine for Ultrasound-Guided Pain Management After Mastectomy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Serratus Anterior Plane BlockErector Spinae Plane BlockDexmedetomidineBupivacaineUltrasoundPain ManagementMastectomy
Interventions
DRUG

Bupivacaine + Dexmedetomidine

Patients received serratus anterior plane block on the operated side with bupivacaine 0.25% plus 0.5 µg/kg dexmedetomidine in 30 ml.

DRUG

Bupivacaine + Dexmedetomidine

Patients received erector spinae plane block at T5 on the operated side and will receive bupivacaine 0.25% plus 0.5 µg/kg dexmedetomidine in 30 ml.

Trial Locations (1)

33516

Kafrelsheikh University, Kafr ash Shaykh

All Listed Sponsors
lead

Kafrelsheikh University

OTHER